Monitoring Plan Development February 2019

Feb 21, 2019
Order the recording of this seminar

Course Description

Although monitoring plans are not defined or specifically required by FDA regulations, the FDA endorses the use of this tool in a Quality Systems management approach to clinical research. The traditional approach to monitoring plan development has relied upon reinforcing SOP-mandated monitoring activities with little focus on project and/or protocol-specific monitoring needs. This web seminar provides participants with concepts and templates to establish a monitoring plan that supports unique project risks and links to valuable data regarding investigative site and Clinical Research Associate (CRA) performance.

Video Preview


Learning Objectives

  • Identify the contents of a monitoring plan including affiliated monitoring procedural documents, tools
  • Develop a monitoring plan to meet the unique needs of a project and protocol
  • Determine the triggers for revisions to monitoring plans and the importance of version control
  • Explain FDA recommendations for risk-based monitoring plans
  • Describe the relationship of the monitoring plan to the CRA for monitoring and managing site performance, meeting project goals and promoting continuous improvement

Who Should Attend

  • Clinical Research Associates
  • Project Managers
  • Clinical Research Associate Managers


Marla Hoelle, R.N., B.S.N., C.C.R.A.-PM, P.M.P.

Click here for complete trainer biographies


Hold this course at your company! For more information, contact Naila Ganatra at +1 215.413.2471.